45
Vimy Pharmaceuticals raises $1.01M in first capital raise from seven investors
Company raise · Closed · Toronto, Ontario · Form D filed 2026-10-13
Vimy Pharmaceuticals Inc., a Toronto-based pharmaceutical company incorporated in 2024, closed a $1.01M offering on September 28, 2026, under Regulation D exemption 6(b) with seven investors. The company engaged Beacon Securities US Limited as placement agent for the raise.
Note: Foreign issuer (Ontario, Canada incorporation); first raise on EDGAR; business combination flag present but no details in filing.
First raise on EDGARPlacement agent engagedBusiness combinationoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| David John Suchon | Chief Executive Officer |
| Farris Smith | President and Chair |
| Darryl Firsten | Director |
| Riccardo Trecroce | Director |
| Christopher Burkett | Director |
Signed by David Suchon, Chief Executive Officer.
Placement agents / sales compensation: Beacon Securities US Limited
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.